Suicidal Ideation: Clinical Trials

6 trials for Suicidal Ideation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated. 6 Phase 2, 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Terminated 6
Phase 33Terminated 3
Phase 11Terminated 1

Follow Suicidal Ideation: new trials by email Literature Review of Suicidal Ideation trials Research Report on Suicidal Ideation

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SAINT for MDD in an Inpatient Setting Follow-on
Active SAINT Stimulation, Sham SAINT Stimulation - Major Depressive Disorder, Major Depressive Episode
Phase 2 / Phase 3TerminatedMagnus Medical22024-06-302025-03-24
The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition
Active SAINT Stimulation, Sham SAINT Stimulation - Major Depressive Disorder, Major Depressive Episode
Phase 2 / Phase 3TerminatedMagnus Medical22024-06-302025-03-24
Ketamine for OUD and Suicidal Ideation in the ED
Ketamine, Saline Solution - Opioid Use Disorder, Suicidal Ideation
Phase 2TerminatedBrigham and Women's Hospital42024-06-142025-04-08
Ketamine Infusion for Rapid Reduction of Suicidality in Pediatrics
Ketamine Injectable Solution, Midazolam Injectable Solution, Normal Saline 0.9% Injectable Solution - Suicidal Ideation
Phase 1 / Phase 2TerminatedUniversity of British Columbia152022-06-012024-12-18
A Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic
OTX-202, OTX-000, Treatment as Usual - Suicide, Attempted, Suicidal Ideation
Phase 2 / Phase 3TerminatedOui Therapeutics, Inc.3562022-04-072025-06-12
Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With Intent
MIJ821 Intravenous Injection, Placebo Intravenous Injection - Major Depressive Disorder With Suicidal Ideation With Intent
Phase 2TerminatedNovartis Pharmaceuticals1992021-07-202026-05-18

Narrower conditions

Depression (3)  ·  Depressive Disorder, Major (3)  ·  Mental Disorders (1)  ·  Mood Disorders (1)  ·  Opioid-Related Disorders (1)  ·  Self-Injurious Behavior (1)  ·  Suicide (1)  ·  Suicide, Attempted (1)

Broader conditions

Behavior (6)  ·  Behavioral Symptoms (6)  ·  Self-Injurious Behavior (5)  ·  Suicide (5)  ·  Depressive Disorder (3)  ·  Mental Disorders (3)  ·  Mood Disorders (2)  ·  Chemically-Induced Disorders (1)  ·  Narcotic-Related Disorders (1)  ·  Substance-Related Disorders (1)

Interventions

Saline Solution (2)  ·  Ketamine (1)  ·  Therapeutics (1)

Sponsors

Magnus Medical (2)  ·  Brigham and Women's Hospital (1)  ·  Novartis Pharmaceuticals (1)  ·  Oui Therapeutics, Inc. (1)  ·  University of British Columbia (1)

Countries

United States (5)  ·  Canada (2)  ·  Argentina (1)  ·  Brazil (1)  ·  Germany (1)  ·  Japan (1)  ·  Malaysia (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Russia (1)  ·  Spain (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)

Top investigators

Brandon Bentzley, MD (2)  ·  Quynh Doan, PhD MHSc MD (1)

Results publications

PMID 40779267, PMID 42234079

NIH funding

R01MH125160 (1), R42MH123357 (1)